Advocacy group seeks ban on pelvic surgical mesh

(AP) -- A consumer advocacy group is calling on government regulators to ban a type of surgical mesh used to treat pelvic collapse, saying it exposes patients to serious risks.

Public Citizen sent a petition to the asking the agency to ban pelvic surgical mesh inserted through the vagina. About 75,000 women had prolapse surgery with forms of the mesh last year, according to the FDA.

FDA announced last month that complications with mesh are higher than previously estimated, with many women experiencing pain, bleeding and infection. Public Citizen said mesh offers no benefit over traditional surgery with stitches.

"Even the FDA seriously questions the safety and effectiveness of these mesh products, so they should be removed from the market immediately," said Public Citizen's Dr. Michael Carome.

5 /5 (1 vote)
add to favorites email to friend print save as pdf

Related Stories

FDA: pelvic mesh for women riskier than thought

Jul 13, 2011

A product commonly used in surgery to treat incontinence and other women's health problems causes far more complications than previously thought and is likely exposing patients to unnecessary risks, according to U.S. health ...

Researchers offer hope to prolapse sufferers

May 17, 2011

Scientists in Scandinavia have found a new way to treat sufferers of pelvic organ prolapse. Presented in the New England Journal of Medicine, their study reveals that the use of synthetic mesh can have a more ...

Synthetic mesh can improve outcome of prolapse surgery

May 12, 2011

(Medical Xpress) -- A Nordic multicentre study, headed by researchers from Karolinska Institutet, shows that pelvic organ prolapse surgery using synthetic mesh can be more effective than traditional surgery. The advantages ...

Watchdog group makes 2nd push to ban diet pill

Apr 18, 2011

(AP) -- For the second time in five years, public health advocates are calling on the Food and Drug Administration to ban a fat-blocking drug sold over-the counter and via prescription, pointing to new reports of kidney ...

Recommended for you

Study recalculates costs of combination vaccines

Apr 17, 2014

One of the most popular vaccine brands for children may not be the most cost-effective choice. And doctors may be overlooking some cost factors when choosing vaccines, driving the market toward what is actually a more expensive ...

Drug watchdog urges vigilance in cancer drug theft

Apr 17, 2014

Europe's medicine watchdog urged doctors Thursday to be vigilant in administering the cancer drug Herceptin, vials of which had been stolen in Italy and tampered with before being sold back into the supply chain.

User comments